Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1840)
|
Core Tip (1605)
|
Full Article (HTML) (14938)
|
Figures (1-3) (354)
|
Tables (1-5) (390)
|
Full Article (PDF)-1451K (1230)
|
Peer-Review Report-94K (374)
|
Answering Reviewers-72K (292)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (60)
|
Total Visits (27507)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1864)
|
Core Tip (1517)
|
Full Article (HTML) (8736)
|
Figures (1-1) (661)
|
Tables (1-3) (325)
|
Full Article (PDF)-1210K (726)
|
Peer-Review Report-98K (314)
|
Answering Reviewers-99K (262)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (17909)
|
Similar Articles (161)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1689)
|
Core Tip (1547)
|
Full Article (HTML) (9438)
|
Figures (1-4) (1096)
|
Tables (1-1) (327)
|
Full Article (PDF)-1374K (1052)
|
Peer-Review Report-105K (305)
|
Answering Reviewers-58K (386)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (19475)
|
Similar Articles (6)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1546)
|
Core Tip (1512)
|
Full Article (HTML) (7023)
|
Figures (1-3) (444)
|
Full Article (PDF)-2317K (792)
|
Peer-Review Report-102K (302)
|
Answering Reviewers-250K (363)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15123)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1329)
|
Core Tip (1230)
|
Full Article (HTML) (4867)
|
Figures (1-1) (320)
|
Tables (1-4) (329)
|
Full Article (PDF)-1455K (686)
|
Peer-Review Report-129K (182)
|
Answering Reviewers-81K (206)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12006)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned

World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1385)
|
Core Tip (1148)
|
Full Article (HTML) (3872)
|
Figures (1-1) (352)
|
Tables (1-1) (313)
|
Full Article (PDF)-2534K (518)
|
Peer-Review Report-98K (247)
|
Answering Reviewers-19K (177)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (11693)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1709)
|
Core Tip (1344)
|
Full Article (HTML) (8254)
|
Figures (1-2) (424)
|
Tables (1-1) (269)
|
Full Article (PDF)-1376K (726)
|
Peer-Review Report-116K (397)
|
Answering Reviewers-78K (330)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (19413)
|
Similar Articles (67)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1682)
|
Core Tip (1533)
|
Full Article (HTML) (7689)
|
Figures (1-2) (301)
|
Tables (1-1) (286)
|
Full Article (PDF)-2415K (508)
|
Peer-Review Report-106K (379)
|
Answering Reviewers-72K (278)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (15658)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding

World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1529)
|
Core Tip (1406)
|
Full Article (HTML) (5412)
|
Figures (1-1) (313)
|
Full Article (PDF)-1040K (563)
|
Peer-Review Report-104K (327)
|
Answering Reviewers-60K (242)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (13123)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1569)
|
Core Tip (1614)
|
Full Article (HTML) (6905)
|
Figures (1-2) (344)
|
Tables (1-1) (290)
|
Full Article (PDF)-4747K (782)
|
Peer-Review Report-116K (337)
|
Answering Reviewers-128K (326)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (18196)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1276)
|
Core Tip (1064)
|
Full Article (HTML) (4393)
|
Tables (1-1) (331)
|
Full Article (PDF)-1054K (405)
|
Peer-Review Report-106K (281)
|
Answering Reviewers-75K (197)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10919)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1492)
|
Core Tip (1153)
|
Full Article (HTML) (6684)
|
Tables (1-2) (320)
|
Full Article (PDF)-872K (644)
|
Peer-Review Report-82K (304)
|
Answering Reviewers-100K (261)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15148)
|
Similar Articles (29)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1304)
|
Core Tip (1061)
|
Full Article (HTML) (2458)
|
Figures (1-2) (258)
|
Tables (1-1) (274)
|
Full Article (PDF)-1053K (356)
|
Peer-Review Report-98K (317)
|
Answering Reviewers-31K (178)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11833)
|
Similar Articles (748)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1483)
|
Core Tip (1330)
|
Full Article (HTML) (6778)
|
Tables (1-4) (411)
|
Full Article (PDF)-1067K (584)
|
Peer-Review Report-118K (291)
|
Answering Reviewers-113K (310)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (14794)
|
Similar Articles (75)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1535)
|
Core Tip (1228)
|
Full Article (HTML) (8896)
|
Figures (1-1) (297)
|
Tables (1-2) (473)
|
Full Article (PDF)-1014K (459)
|
Peer-Review Report-80K (284)
|
Answering Reviewers-67K (220)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (17161)
|
Similar Articles (222)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open